liothyronine sodium
liothyronine sodium is listed in the FDA National Drug Code directory with 10 NDC codes, marketed under brand names including Liothyronine Sodium, Cytomel, liothyronine sodium. Available dosage form: tablet.
Drug details
- Generic Name
- liothyronine sodium
- Brand Names
- Liothyronine Sodium, Cytomel, liothyronine sodium
- Application Number
- NDA010379
- Sponsor
- Mylan Pharmaceuticals Inc.
- NDC Codes
- 10
- Dosage Forms
- TABLET
- Routes
- ORAL
- Active Ingredients
- LIOTHYRONINE SODIUM
Indications and Usage
1 INDICATIONS AND USAGE Liothyronine sodium is an L-triiodothyronine (T3) indicated for: • Hypothyroidism: As replacement in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism ( 1.1 ) • Pituitary Thyroid-Stimulating Hormone (TSH) Suppression: As an adjunct to surgery and radioiodine therapy in the management of well-differentiated thyroid cancer ( 1.2 ) • Thyroid Suppression Test: As a diagnostic agent in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy ( 1.3 ) Limitations of Use : - Not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients. ( 1 ) - Not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis. ( 1 ) 1.1 Hypothyroidism Liothyronine sodium is indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. 1.2 Pituitary Thyroid-Stimulating Hormone (TSH) Suppression Liothyronine sodium is indicated as an adjunct to surgery and radioiodine therapy in the management of well-differentiated thyroid cancer . 1.3 Thyroid Suppression Test Liothyronine sodium is indicated as a diagnostic agent in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy. Limitations of Use • Liothyronine sodium is not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with liothyronine sodium may induce hyperthyroidism [see Warnings and Precautions (5.4) ] . • Liothyronine sodium is not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis.